Guangzhou Baiy reported CNY16.05B in Sales Revenues for its fiscal quarter ending in December of 2026.





Sales Change Date
Aspen Pharmacare ZAR 17.08B 4.32B Dec/2025
Cipla INR 65.41B 9.77B Mar/2026
Dr.Reddys Laboratories INR 75.46B 11.81B Mar/2026
Jiangsu Hengrui CNY 8.14B 300M Mar/2026
Kalbe Farma IDR 9.34T 431B Mar/2026
Richter Gedeon HUF 220.2B 5.51B Mar/2026
Sh Fosun Pharma CNY 10.07B 260M Dec/2026
Sh Pharmaceutical CNY 68.51B 4.97B Mar/2026
Sun Pharmaceuticals INR 145.86B 2.13B Mar/2026
Teva Pharmaceutical Industries USD 11.77B 2.86B Mar/2026